Andriukaitis: SPC manufacturing waiver does not damage pharma innovation

12 June 2018

IGBA Joins ICH Management Committee and Welcomes the Positive Vote of the General Assembly

7 June 2018

Comprehensive SPC manufacturing waiver key for patient access to medicines, jobs and growth in Europe

28 May 2018

Medicines for Europe commends the European Commission for proposing an […]

EU Semester Country Specific Recommendations: Improve patient access to medicine and ensure healthcare sustainability

24 May 2018

The European Semester Country Specific Recommendations show that healthcare systems […]

Generics driving pharmerging market growth? ‘There is still opportunity for EU’ says Medicines for Europe

22 May 2018

Up to 25,000 pharma jobs if EU alters patent rules

21 May 2018

Biosimilar Medicines: essential for sustainable access to medicines

26 April 2018

Opening the 16th Biosimilar Medicines Conference, Keith Ridge, Chief Pharmaceutical […]

Access to Biosimilars in EU Expected to Continue to Outpace US and Canada

26 April 2018

SPC manufacturing waiver, Competition policy, Brexit, pharma incentives European Patent Office take centre stage at 14^th Legal Affairs Conference

25 April 2018

Key authorities, lawyers and industry leaders discussed today in London […]

Stakeholders To Gather In London To Plan Biosimilar Market’s Future

17 April 2018